Related references
Note: Only part of the references are listed.Trends in clinical development for PD-1/PD-L1 inhibitors
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
Khalil Choucair et al.
CANCER GENE THERAPY (2020)
Dendritic cells in tumor microenvironment promoted the neuropathic pain via paracrine inflammatory and growth factors
Zhun Wang et al.
BIOENGINEERED (2020)
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma
M. J. M. van Velzen et al.
CANCER TREATMENT REVIEWS (2020)
Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer
Shihori Tanabe et al.
CANCERS (2020)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
Cancer immunotherapy: the art of targeting the tumor immune microenvironment
Jesse Lopes da Silva et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
Dae-Won Lee et al.
CLINICAL CANCER RESEARCH (2019)
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci
Juncheng Dai et al.
CARCINOGENESIS (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
CTLA-4 (CD152): A versatile receptor for immune-based therapy
Holger Lingel et al.
SEMINARS IN IMMUNOLOGY (2019)
The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC)
Tao Lianyuan et al.
CANCER BIOLOGY & THERAPY (2018)
CANCER Re-educating tumour-associated macrophages with nanoparticles
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2018)
DNA mismatch repair in cancer
Marina Baretti et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Role and alterations of DNA methylation during the aging and cancer
Szigeti Krisztina Andrea et al.
ORVOSI HETILAP (2018)
MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells
Saya Ito et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2018)
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer
Siddhartha Devarakonda et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
Feng Ding et al.
ONCOTARGET (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade
Valerie Lee et al.
ONCOLOGIST (2016)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
A genetic screen in Drosophila for regulators of human prostate cancer progression
Saya Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
MRG-binding protein contributes to colorectal cancer development
Kiyoshi Yamaguchi et al.
CANCER SCIENCE (2011)
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma
S. A. Watt et al.
ONCOGENE (2011)
C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer
K. Yamaguchi et al.
BRITISH JOURNAL OF CANCER (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression
B. Carvalho et al.
GUT (2009)
Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression
Luigi Scotto et al.
GENES CHROMOSOMES & CANCER (2008)
Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex
Y Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
